StockData

Community Healthcare Trust vs Chiron Real Estate

CHCT and XRN side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CHCT and XRN compare

Community Healthcare Trust and Chiron Real Estate are about the same size, with market caps of $374M and $402M.

On earnings, Chiron Real Estate is cheaper: it trades at 8.2× trailing earnings, against 19.5× for Community Healthcare Trust.

Chiron Real Estate grew revenue faster over the last twelve months (8.0% versus 5.7% for Community Healthcare Trust).

Both pay dividends: Community Healthcare Trust yields 13.5% and Chiron Real Estate 7.0%.

Community Healthcare Trust scores higher on the StockData Score (13 against 10 for Chiron Real Estate), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCHCTXRN
Size and price
Market cap$374M$402M
Share price$13.06$30.37
Change, 1 year−9.5%−2.3%
Change, 5 years−72.6%−64.4%
Beta (5Y)0.680.87
Employees3530
StockData Score
Total score13 (better)10
Valuation score55
Growth score11
Performance score3 (better)0
Health score00
Dividend score44
Valuation
P/E19.5×8.2× (better)
P/S3.0×2.6× (better)
P/B0.9×0.6× (better)
Fair value$24.20$103.94
Margin of safety46.0%70.8% (better)
Growth
Revenue growth (TTM)5.7%8.0% (better)
Revenue growth, 5Y average9.9% (better)9.6%
EPS growth (TTM)–994%
EPS growth, 5Y average−36.9%–
Profitability
Net margin16.8%–
Return on equity4.9%–
Financial health
Altman Z-score0.51 (better)0.15
Piotroski F-score5–
Dividends and buybacks
Dividend yield13.5% (better)7.0%
Payout ratio260%–
Years of dividend growth10–
Dividend growth, 5Y average2.3%–
Shareholder yield13.5% (better)7.0%
Ownership
Held by institutions80.8%75.2%
Held by insiders6.8%2.3%
Insider net buying, 12 months$332K$4.0M (better)
Superinvestors holding1–
Short interest, % of float3.2%7.3%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.